Trial
NCT06097260
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Pliant Therapeutics, Inc.
Collaborators
—
Condition
Idiopathic Pulmonary Fibrosis
Intervention
PLN-74809
Why stopped
DSMB recommendation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-01